16th Annual Heart Failure Holiday Symposium

 

16th Annual Heart Failure Holiday Symposium
Avatar

Updates in Treatment Approaches to HFpEF: What Is the Phenotype-guided Approach? Could NP-rGC-PDE9-cGMP-PKG Pathway Drugs Be Effective?

By 16th Annual Heart Failure Holiday Symposium FEATURING Sanjiv J. Shah
By 16th Annual Heart Failure Holiday Symposium FEATURING Sanjiv J. Shah
0 views
February 18, 2021
Comments 1
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus
Videos
25:01
16th Annual Heart Failure Holiday Symposium

New Treatment Approaches to HFrEF: When to Use SGLT2, Vericiguat, Om…

Feat. M. Drazner
17:01
16th Annual Heart Failure Holiday Symposium

Updates in Treatment Approaches to HFpEF: What Is the Phenotype-guid…

Feat. S. Shah
15:35
16th Annual Heart Failure Holiday Symposium

Implications of New HF Therapies on HF Guidelines: Is the SGLT2i Dru…

Feat. C. Yancy
13:55
16th Annual Heart Failure Holiday Symposium

HF Treatment: Can the Use of SGLT2i Provoke Diuresis? How to Clinica…

Feat. J. Wilcox, S. Shah, M. Drazner, C. Yancy, J. Rich
16:50
16th Annual Heart Failure Holiday Symposium

Cardiac Amyloidosis vs. Cardiorenal Syndrome: How to Diagnose and Tr…

Feat. M. Grogan
16:26
16th Annual Heart Failure Holiday Symposium

Updates in Heart Transplantation: How to Use Personalized Medicine i…

Feat. K. Ghafourian
08:33
16th Annual Heart Failure Holiday Symposium

Who Needs a Biopsy for Diagnosing TTR Amyloidosis? What Is the Role …

Feat. J. Rich, M. Grogan, S. Shah, K. Ghafourian